日本新薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/04/04 | 5,920 | 5,920 | 5,820 | 5,900 | +20 | +0.3% | 260,100 |
| 2023/04/03 | 5,850 | 5,940 | 5,840 | 5,880 | +50 | +0.9% | 323,200 |
| 2023/03/31 | 5,820 | 5,850 | 5,750 | 5,830 | ±0 | ±0% | 347,100 |
| 2023/03/30 | 5,880 | 5,900 | 5,780 | 5,830 | -110 | -1.9% | 226,800 |
| 2023/03/29 | 5,940 | 5,940 | 5,850 | 5,940 | +10 | +0.2% | 309,000 |
| 2023/03/28 | 5,940 | 5,960 | 5,870 | 5,930 | +30 | +0.5% | 263,400 |
| 2023/03/27 | 5,920 | 5,980 | 5,880 | 5,900 | -10 | -0.2% | 242,600 |
| 2023/03/24 | 5,890 | 5,930 | 5,860 | 5,910 | +30 | +0.5% | 240,000 |
| 2023/03/23 | 5,900 | 5,920 | 5,850 | 5,880 | -70 | -1.2% | 319,500 |
| 2023/03/22 | 5,950 | 6,020 | 5,900 | 5,950 | +100 | +1.7% | 425,500 |
| 2023/03/20 | 5,860 | 6,000 | 5,780 | 5,850 | -140 | -2.3% | 680,800 |
| 2023/03/17 | 5,600 | 6,010 | 5,590 | 5,990 | +610 | +11.3% | 1,473,300 |
| 2023/03/16 | 5,360 | 5,420 | 5,260 | 5,380 | -50 | -0.9% | 602,400 |
| 2023/03/15 | 5,510 | 5,570 | 5,430 | 5,430 | -30 | -0.5% | 391,900 |
| 2023/03/14 | 5,540 | 5,540 | 5,410 | 5,460 | -110 | -2% | 433,100 |
| 2023/03/13 | 5,660 | 5,700 | 5,530 | 5,570 | -120 | -2.1% | 519,700 |
| 2023/03/10 | 5,740 | 5,790 | 5,680 | 5,690 | -150 | -2.6% | 636,400 |
| 2023/03/09 | 5,910 | 5,920 | 5,830 | 5,840 | -30 | -0.5% | 435,600 |
| 2023/03/08 | 5,860 | 5,910 | 5,790 | 5,870 | ±0 | ±0% | 583,600 |
| 2023/03/07 | 5,880 | 5,940 | 5,840 | 5,870 | -70 | -1.2% | 457,100 |
| 2023/03/06 | 5,990 | 6,000 | 5,890 | 5,940 | -20 | -0.3% | 318,800 |
| 2023/03/03 | 5,890 | 6,000 | 5,870 | 5,960 | +70 | +1.2% | 428,700 |
| 2023/03/02 | 5,810 | 5,960 | 5,810 | 5,890 | -10 | -0.2% | 395,300 |
| 2023/03/01 | 6,010 | 6,050 | 5,900 | 5,900 | -200 | -3.3% | 413,400 |
| 2023/02/28 | 6,110 | 6,180 | 6,040 | 6,100 | +20 | +0.3% | 493,800 |
| 2023/02/27 | 6,060 | 6,080 | 6,010 | 6,080 | -30 | -0.5% | 415,100 |
| 2023/02/24 | 6,180 | 6,180 | 6,100 | 6,110 | -160 | -2.6% | 439,000 |
| 2023/02/22 | 6,300 | 6,390 | 6,260 | 6,270 | -40 | -0.6% | 291,400 |
| 2023/02/21 | 6,340 | 6,360 | 6,270 | 6,310 | ±0 | ±0% | 155,400 |
| 2023/02/20 | 6,320 | 6,390 | 6,260 | 6,310 | +50 | +0.8% | 328,800 |
| 2023/02/17 | 6,270 | 6,290 | 6,190 | 6,260 | -50 | -0.8% | 432,200 |
| 2023/02/16 | 6,430 | 6,450 | 6,300 | 6,310 | -120 | -1.9% | 342,700 |
| 2023/02/15 | 6,550 | 6,550 | 6,410 | 6,430 | -130 | -2% | 237,700 |
| 2023/02/14 | 6,580 | 6,590 | 6,510 | 6,560 | +80 | +1.2% | 185,700 |
| 2023/02/13 | 6,630 | 6,680 | 6,460 | 6,480 | -150 | -2.3% | 309,400 |
| 2023/02/10 | 6,600 | 6,630 | 6,570 | 6,630 | -30 | -0.5% | 201,200 |
| 2023/02/09 | 6,650 | 6,670 | 6,620 | 6,660 | -40 | -0.6% | 134,600 |
| 2023/02/08 | 6,670 | 6,730 | 6,630 | 6,700 | +110 | +1.7% | 236,900 |
| 2023/02/07 | 6,640 | 6,660 | 6,590 | 6,590 | -50 | -0.8% | 148,100 |
| 2023/02/06 | 6,640 | 6,680 | 6,600 | 6,640 | +50 | +0.8% | 158,900 |
| 2023/02/03 | 6,630 | 6,650 | 6,560 | 6,590 | -110 | -1.6% | 217,100 |
| 2023/02/02 | 6,740 | 6,740 | 6,660 | 6,700 | ±0 | ±0% | 194,400 |
| 2023/02/01 | 6,710 | 6,750 | 6,680 | 6,700 | +30 | +0.4% | 197,100 |
| 2023/01/31 | 6,700 | 6,730 | 6,670 | 6,670 | -50 | -0.7% | 160,300 |
| 2023/01/30 | 6,720 | 6,790 | 6,700 | 6,720 | +40 | +0.6% | 307,600 |
| 2023/01/27 | 6,700 | 6,740 | 6,670 | 6,680 | -50 | -0.7% | 177,200 |
| 2023/01/26 | 6,760 | 6,780 | 6,700 | 6,730 | -30 | -0.4% | 201,700 |
| 2023/01/25 | 6,740 | 6,760 | 6,680 | 6,760 | +20 | +0.3% | 251,100 |
| 2023/01/24 | 6,780 | 6,790 | 6,680 | 6,740 | +20 | +0.3% | 372,800 |
| 2023/01/23 | 6,710 | 6,810 | 6,710 | 6,720 | +30 | +0.4% | 273,300 |
501～
550
件表示中 / 3683件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日本新薬 | 362,200円 | +7.9% | +8.9% | 3.42% | 7.75倍 | 1.04倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| 住友ファーマ | 70,800円 | +21.1% | - | 0.00% | 17.58倍 | 2.47倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
| サワイＧＨＤ | 196,000円 | +4.0% | +25.4% | 2.70% | 8.57倍 | 1.13倍 |
|
ジェネリック（後発）薬大手メーカー。２１年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
| ペプチド | 187,000円 | +5.0% | +1.5% | 0.00% | 16.05倍 | 4.27倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| 科研薬 | 409,100円 | +30.5% | +111.0% | 4.64% | 11.53倍 | 1.01倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
市場注目の銘柄
チャート関連のコラム
